You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
金斯瑞生物科技(01548.HK)斥2.6億人幣收購江蘇物業擴產
阿思達克 06-30 09:34
金斯瑞生物科技(01548.HK)公布,間接非全資附屬公司江蘇蓬勃向瀚瑞經營及瀚瑞投資分別收購四幢樓宇及一幢樓宇,及間接全資附屬江蘇金斯瑞同意向瀚瑞經營收購三幢樓宇。所有八幢樓宇均位於江蘇省鎮江市科技園開發區,總代價約2.6億元人民幣。 該等物業總獨用土地使用權面積約3.37萬平方米,建築面積約5.48萬平方米。公司擬將該等物業用作工廠,以擴大生物製劑產品的產能,包括良好生產規範質粒及病毒載體等。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account